Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice.
Mukherjee S, Raje N, Schoonmaker JA, Liu JC, Hideshima T, Wein MN, Jones DC, Vallet S, Bouxsein ML, Pozzi S, Chhetri S, Seo YD, Aronson JP, Patel C, Fulciniti M, Purton LE, Glimcher LH, Lian JB, Stein G, Anderson KC, Scadden DT.
Mukherjee S, et al. Among authors: anderson kc.
J Clin Invest. 2008 Feb;118(2):491-504. doi: 10.1172/JCI33102.
J Clin Invest. 2008.
PMID: 18219387
Free PMC article.